Cinacalcet Hydrochloride

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

Virtual Booth

Contact Supplier

Check COS database
Check all USDMF suppliers

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 25 USDMF, 3 JDMF, 20 EU WC, 12 KDMF, 16 NDC API, 40 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

218 FDF Dossiers, 52 FDA Orange Book, 70 Europe, 31 Canada, 30 Australia, 4 South Africa, 31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 60MG BASE, TABLET;ORAL - EQ 90MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 14 BASF, 2 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 2 Kerry, 1 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 13 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 21 Direct Compression, 20 Disintegrants & Superdisintegrants, 15 Granulation, 13 Thickeners and Stabilizers, 10 Co-Processed Excipients, 10 Lubricants & Glidants, 10 Chewable & Orodispersible Aids, 8 Solubilizers, 6 Controlled & Modified Release, 5 Taste Masking, 3 Coating Systems & Additives, 3 Emulsifying Agents, 2 Parenteral, 2 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Rheology Modifiers

DIGITAL CONTENT

43 News #PharmaBuzz

43 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 17 Annual Reports

MARKET PLACE

5 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

18 Others

18 Others

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Dr. Reddy's Laboratories

India

CPhI WW Frankfurt

Booth #9.1B48

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Lead Product(s) : Cinacalcet Hydrochloride

Therapeutic Area : Endocrinology

Study Phase : Approved FDF

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

DEALS_DEV

Dr. Reddy's Laboratories Announces the Launch of Cinacalcet Tablets in the U.S. Market

Details : Cinacalcet Tablets is a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

January 10, 2020

Lead Product(s) : Cinacalcet Hydrochloride

Therapeutic Area : Endocrinology

Highest Development Status : Approved FDF

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Virtual Booth

02

Amgen Inc

U.S.A

U.S.A

iPHEX India

Not Confirmed

Find Clinical Drug Pipeline Developments & Deals for Cinacalcet Hydrochloride